BiotechTube
Home/Signatur Biosciences/Celestin de Wergifosse
CD

Celestin de Wergifosse

CEO & Co-founder

Signatur Biosciences

Therapeutic Areas

Oncology

Signatur Biosciences Pipeline

DrugIndicationPhase
PCRchitectur-based Prognostic TestBreast Cancer PrognosisDevelopment

Leadership Team at Signatur Biosciences

PD
Prof. Dame Molly Stevens DBE FRS FREng
Scientific Advisory Board Chair & Co-inventor
DJ
Dr. John Goertz
Scientific Advisor & Co-inventor
DA
Dr. Adrian Moody
Chief Development Officer
View full Signatur Biosciences profile